Meta-Analysis of Transcriptomic Datasets Identifies Genes Enriched

Total Page:16

File Type:pdf, Size:1020Kb

Meta-Analysis of Transcriptomic Datasets Identifies Genes Enriched 9860–9873 Nucleic Acids Research, 2017, Vol. 45, No. 17 Published online 18 August 2017 doi: 10.1093/nar/gkx714 Meta-analysis of transcriptomic datasets identifies genes enriched in the mammalian circadian pacemaker Laurence A. Brown1, John Williams2, Lewis Taylor1, Ross J. Thomson1,PatrickM.Nolan2, Russell G. Foster1,* and Stuart N. Peirson1,* 1Sleep and Circadian Neuroscience Institute (SCNi), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX1 3RE, UK and 2MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK Received September 07, 2016; Revised July 27, 2017; Editorial Decision July 30, 2017; Accepted August 04, 2017 ABSTRACT of an endogenous biological clock. In mammals, the site of the master circadian pacemaker is the suprachiasmatic The master circadian pacemaker in mammals is lo- nuclei (SCN) in the anterior hypothalamus (1). The SCN cated in the suprachiasmatic nuclei (SCN) which reg- receives light information from the retina via the retinohy- ulate physiology and behaviour, as well as coordi- pothalamic tract, synchronizing (entraining) SCN rhythms nating peripheral clocks throughout the body. In- to the external environment. SCN lesions result in loss of vestigating the function of the SCN has often fo- physiological and behavioural rhythms, and transplanta- cused on the identification of rhythmically expressed tion of foetal SCN can restore rhythmicity with a period genes. However, not all genes critical for SCN func- consistent with that of the donor tissue (2). The circa- tion are rhythmically expressed. An alternative strat- dian clock is the product of an intracellular transcriptional- egy is to characterize those genes that are selec- translational feedback loop (TTFL), comprised of a num- tively enriched in the SCN. Here, we examined the ber of so-called ‘clock genes’. Whilst clock genes are ex- pressed in tissues throughout the body, the coordinated transcriptome of the SCN and whole brain (WB) of function of the circadian system depends upon neural, hor- mice using meta-analysis of publicly deposited data monal and behavioural output of the SCN pacemaker (3– across a range of microarray platforms and RNA- 5). Seq data. A total of 79 microarrays were used (24 The identification of mammalian clock genes has crit- SCN and 55 WB samples, 4 different microarray plat- ically depended upon the application of forward and re- forms), alongside 17 RNA-Seq data files (7 SCN and verse genetics. Large scale mutagenesis projects have been 10 WB). 31 684 MGI gene symbols had data for at invaluable in identifying novel mouse mutants with circa- least one platform. Meta-analysis using a random ef- dian phenotypes. Mapping the underlying mutation has led fects model for weighting individual effect sizes (de- to the identification of a number of key clock genes, includ- rived from differential expression between relevant ing Clock (6), Fbxl3 (7), Fbxl21 (8)andZfhx3 (9). By con- SCN and WB samples) reliably detected known SCN trast, reverse genetics has been used to identify homologs of Drosophila clock genes (identified by forward genetics), in- markers. SCN-enriched transcripts identified in this cluding Period 1–3 (10–12)andCryptochrome 1–2 (13,14)as study provide novel insights into SCN function, in- well as proteins that interact with known clock components, cluding identifying genes which may play key roles such as Arntl (Bmal1, (15)). A key feature of many of the in SCN physiology or provide SCN-specific drivers. core clock genes is that they are rhythmically expressed over the 24-h cycle. Therefore, studies to identify new clock genes INTRODUCTION have often taken the approach of identifying transcripts that are rhythmically expressed in the SCN or other periph- Life on Earth has evolved under a predictably changing cy- eral clocks, under either entrained light/dark conditions or cle of light and darkness and, as a result, virtually all or- over one or more circadian cycles under constant conditions ganisms demonstrate striking changes in physiology and be- (16). These studies have been successful in identifying novel haviour over the 24-h day. These rhythms are not simply clock genes as well as genes important for SCN function a response to the changing environment, but persist under (17,18). However, not all clock genes are rhythmically ex- constant conditions––providing evidence for the existence *To whom correspondence should be addressed. Tel: +44 0 1865 618 674; Email: [email protected] Correspondence may also be addressed to Russell G. Foster. Tel: +44 0 1865 618 661; Email: [email protected] C The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Nucleic Acids Research, 2017, Vol. 45, No. 17 9861 pressed, and rather than changing in abundance, some com- numbers of transcripts. The methods for drawing together ponents of the TTFL may show rhythmic post-translational a series of experiments with differing biological and techni- modification or simply depend upon interactions with other cal variance are numerous, and depend partly on the quality rhythmic components. Moreover, many genes involved in and detail of the available data. Where only lists of signifi- key functions of the SCN are not elements of the TTFL. cant genes are available, methods such as vote-counting pro- For example, a number of neuropeptides and their receptors vide the most straightforward approach to meta-analysis play key roles in SCN physiology (such as vasoactive intesti- (30). Venn-diagrams are often used as a simple form of vote nal polypeptide, VIP (19)andVIPR2(20)), as do GABA counting, focusing on genes that pass both a fold-change receptors (21). criteria and one or more statistical tests. A problem of this An alternative strategy to identify mechanisms critical for approach is that the pre-processing methods and inclusion SCN function is to characterize those genes that are selec- criteria used by the original authors to construct each gene tively enriched in the SCN. The most straightforward way of list are unlikely to be comparable across all data sources identifying SCN-enriched genes is to directly compare the (16). Alternative approaches make use of original raw data transcriptome of SCN against the whole brain. Despite the by combining either rank-orders of genes (31)orP-values value of this approach, only a few such studies exist - focus- as measures of significance (32). Finally, weighting the con- ing on multiple brain regions (22), or specifically on a subset tribution of each data point for a gene by the inverse of of genes (23). Another advantage of this approach is that it the variance of that data provides a way of comparing data enables SCN-specific genes to be identified, providing criti- across studies, assuming that lower variance is an indicator cal tools for conditional transgenesis. As many clock genes of reproducibility (33). These methods are discussed in de- are expressed throughout the body, studies of constitutive tail by Ramasamy et al.(34), which provides the basis for knockout mouse models can be problematic due to develop- our analysis. mental effects or differing roles of these genes in other target Here, we describe a meta-analysis of expression data from tissues/organs. As a result, many researchers are looking to SCN and whole brain across a range of microarray tech- the use of conditional knockouts, for example, using Cre- nologies and incorporating recent RNA-Seq data (Figure lox technology (24,25). The identification of genes that are 1). We use the term ‘platform’ in the rest of the paper to specifically and highly enriched in the SCN may not only refer to each different type of microarray technology (e.g. reveal new biological insights regarding SCN physiology, Mouse Exon ST1.0 arrays) or RNA-Sequencing. This meta- but also has the potential to produce SCN-specific drivers, analysis enables us to reliably identify transcripts enriched which would be of benefit to the circadian community. in the SCN. These transcripts provide novel insights into the Studies using transcriptomic approaches face several function of the master circadian pacemaker, providing new well-characterized challenges (26). Biological and technical candidates that may play key roles in SCN function, as well variance result in a degree of noise in any study, but when as providing new targets for SCN-specific gene targeting. making comparisons between thousands of genes, false pos- itive rates become a major problem. Using P < 0.05, com- MATERIALS AND METHODS paring the expression of ∼20 000 transcripts would be ex- Data-mining to identify SCN and WB datasets for pected to give 1000 false positives––genes that would ap- Affymetrix platforms pear significant even though they are unchanged. As such, false discovery rates are corrected to account for this issue. Analysis of publicly available datasets revealed that a large However, due to the cost of running transcriptomic exper- part of the apparent variation in any comparison was at- iments, sample sizes are often limited. This results in re- tributable to differences in the different array platforms. For duced power––that is the ability to identify real differences this reason samples from a particular microarray platform where they exist, which can result in biologically relevant could only be used if both SCN and whole brain (WB) data findings being missed. As such, transcriptomic studies are were available for that platform. In addition, investigations often a statistical balancing act––resulting in a list of candi- were limited to the Affymetrix microarray platforms (by far date genes which may contain false positives, and may be the most prominent platforms with suitable data) and we missing real genes of interest.
Recommended publications
  • Prdm16 Is Required for the Maintenance of Neural Stem Cells in the Postnatal Forebrain and Their Differentiation Into Ependymal Cells
    Downloaded from genesdev.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Prdm16 is required for the maintenance of neural stem cells in the postnatal forebrain and their differentiation into ependymal cells Issei S. Shimada,1,2 Melih Acar,1,2,3 Rebecca J. Burgess,1,2 Zhiyu Zhao,1,2 and Sean J. Morrison1,2,4 1Children’s Research Institute, 2Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA; 3Bahcesehir University, School of Medicine, Istanbul 34734, Turkey; 4Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA We and others showed previously that PR domain-containing 16 (Prdm16) is a transcriptional regulator required for stem cell function in multiple fetal and neonatal tissues, including the nervous system. However, Prdm16 germline knockout mice died neonatally, preventing us from testing whether Prdm16 is also required for adult stem cell function. Here we demonstrate that Prdm16 is required for neural stem cell maintenance and neurogenesis in the adult lateral ventricle subventricular zone and dentate gyrus. We also discovered that Prdm16 is required for the formation of ciliated ependymal cells in the lateral ventricle. Conditional Prdm16 deletion during fetal development using Nestin-Cre prevented the formation of ependymal cells, disrupting cerebrospinal fluid flow and causing hy- drocephalus. Postnatal Prdm16 deletion using Nestin-CreERT2 did not cause hydrocephalus or prevent the forma- tion of ciliated ependymal cells but caused defects in their differentiation. Prdm16 was required in neural stem/ progenitor cells for the expression of Foxj1, a transcription factor that promotes ependymal cell differentiation.
    [Show full text]
  • The Roles of Histone Deacetylase 5 and the Histone Methyltransferase Adaptor WDR5 in Myc Oncogenesis
    The Roles of Histone Deacetylase 5 and the Histone Methyltransferase Adaptor WDR5 in Myc oncogenesis By Yuting Sun This thesis is submitted in fulfilment of the requirements for the degree of Doctor of Philosophy at the University of New South Wales Children’s Cancer Institute Australia for Medical Research School of Women’s and Children’s Health, Faculty of Medicine University of New South Wales Australia August 2014 PLEASE TYPE THE UNIVERSITY OF NEW SOUTH WALES Thesis/Dissertation Sheet Surname or Family name: Sun First name: Yuting Other name/s: Abbreviation for degree as given in the University calendar: PhD School : School of·Women's and Children's Health Faculty: Faculty of Medicine Title: The Roles of Histone Deacetylase 5 and the Histone Methyltransferase Adaptor WDR5 in Myc oncogenesis. Abstract 350 words maximum: (PLEASE TYPE) N-Myc Induces neuroblastoma by regulating the expression of target genes and proteins, and N-Myc protein is degraded by Fbxw7 and NEDD4 and stabilized by Aurora A. The class lla histone deacetylase HDAC5 suppresses gene transcription, and blocks myoblast and leukaemia cell differentiation. While histone H3 lysine 4 (H3K4) trimethylation at target gene promoters is a pre-requisite for Myc· induced transcriptional activation, WDRS, as a histone H3K4 methyltransferase presenter, is required for H3K4 methylation and transcriptional activation mediated by a histone H3K4 methyltransferase complex. Here, I investigated the roles of HDAC5 and WDR5 in N-Myc overexpressing neuroblastoma. I have found that N-Myc upregulates HDAC5 protein expression, and that HDAC5 represses NEDD4 gene expression, increases Aurora A gene expression and consequently upregulates N-Myc protein expression in neuroblastoma cells.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Primate Specific Retrotransposons, Svas, in the Evolution of Networks That Alter Brain Function
    Title: Primate specific retrotransposons, SVAs, in the evolution of networks that alter brain function. Olga Vasieva1*, Sultan Cetiner1, Abigail Savage2, Gerald G. Schumann3, Vivien J Bubb2, John P Quinn2*, 1 Institute of Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, U.K 2 Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, The University of Liverpool, Liverpool L69 3BX, UK 3 Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, D-63225 Germany *. Corresponding author Olga Vasieva: Institute of Integrative Biology, Department of Comparative genomics, University of Liverpool, Liverpool, L69 7ZB, [email protected] ; Tel: (+44) 151 795 4456; FAX:(+44) 151 795 4406 John Quinn: Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, The University of Liverpool, Liverpool L69 3BX, UK, [email protected]; Tel: (+44) 151 794 5498. Key words: SVA, trans-mobilisation, behaviour, brain, evolution, psychiatric disorders 1 Abstract The hominid-specific non-LTR retrotransposon termed SINE–VNTR–Alu (SVA) is the youngest of the transposable elements in the human genome. The propagation of the most ancient SVA type A took place about 13.5 Myrs ago, and the youngest SVA types appeared in the human genome after the chimpanzee divergence. Functional enrichment analysis of genes associated with SVA insertions demonstrated their strong link to multiple ontological categories attributed to brain function and the disorders. SVA types that expanded their presence in the human genome at different stages of hominoid life history were also associated with progressively evolving behavioural features that indicated a potential impact of SVA propagation on a cognitive ability of a modern human.
    [Show full text]
  • GINS1/2/3/4 Upregulation Predicts Poor Prognosis in Human Sarcoma
    GINS1/2/3/4 Upregulation Predicts Poor Prognosis in Human Sarcoma Gen Wu Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011 Ziyuan Chen Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011 Tong Wu Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011 Jian Zhou Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011 Qunyan Tian Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011 Ren Wu Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011 Pengcheng Dou Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011 Shuo Jie Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011 Wanchun Wang ( [email protected] ) Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China Research Article Keywords: Sarcoma, Bioinformatics analysis, Prognosis, GEPIA, GINS Posted Date: January 22nd, 2021 Page 1/18 DOI: https://doi.org/10.21203/rs.3.rs-140815/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 2/18 Abstract Background: GINS family was reported to be highly expressed in many tumors. However, the association of GINS family with human sarcoma remained unknown. This study was undertaken to explore the expression and prognostic value of GINS family in human sarcoma. Methods: In terms of the expression levels of mRNA for GINS family members, a particular contrast in various cancers, especially human sarcoma, was conducted through ONCOMINE and GEPIA and CCLE databases.
    [Show full text]
  • Targeted Pharmacological Therapy Restores Β-Cell Function for Diabetes Remission
    Targeted pharmacological therapy restores -cell function for diabetes remission Sachs, Stephan; Bastidas-Ponce, Aimée; Tritschler, Sophie; Bakhti, Mostafa; Böttcher, Anika; Sánchez-Garrido, Miguel A; Tarquis-Medina, Marta; Kleinert, Maximilian; Fischer, Katrin; Jall, Sigrid; Harger, Alexandra; Bader, Erik; Roscioni, Sara; Ussar, Siegfried; Feuchtinger, Annette; Yesildag, Burcak; Neelakandhan, Aparna; Jensen, Christine B; Cornu, Marion; Yang, Bin; Finan, Brian; DiMarchi, Richard D; Tschöp, Matthias H; Theis, Fabian J; Hofmann, Susanna M.; Müller, Timo D; Lickert, Heiko Published in: Nature Metabolism DOI: 10.1038/s42255-020-0171-3 Publication date: 2020 Document version Publisher's PDF, also known as Version of record Document license: CC BY Citation for published version (APA): Sachs, S., Bastidas-Ponce, A., Tritschler, S., Bakhti, M., Böttcher, A., Sánchez-Garrido, M. A., Tarquis-Medina, M., Kleinert, M., Fischer, K., Jall, S., Harger, A., Bader, E., Roscioni, S., Ussar, S., Feuchtinger, A., Yesildag, B., Neelakandhan, A., Jensen, C. B., Cornu, M., ... Lickert, H. (2020). Targeted pharmacological therapy restores - cell function for diabetes remission. Nature Metabolism, 2(2), 192-209. https://doi.org/10.1038/s42255-020- 0171-3 Download date: 05. Oct. 2021 ARTICLES https://doi.org/10.1038/s42255-020-0171-3 There are amendments to this paper Targeted pharmacological therapy restores β-cell function for diabetes remission Stephan Sachs1,2,3,4,19, Aimée Bastidas-Ponce1,4,5,6,19, Sophie Tritschler1,4,7,8,19, Mostafa Bakhti 1,4,5, Anika Böttcher1,4,5, Miguel A. Sánchez-Garrido2, Marta Tarquis-Medina1,4,5,6, Maximilian Kleinert2,9, Katrin Fischer2,3, Sigrid Jall2,3, Alexandra Harger2, Erik Bader1, Sara Roscioni1, Siegfried Ussar 4,6,10, Annette Feuchtinger11, Burcak Yesildag12, Aparna Neelakandhan12, Christine B.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene
    Hodgkin Lymphoma SUPPLEMENTARY APPENDIX Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene Melissa Rotunno, 1 Mary L. McMaster, 1 Joseph Boland, 2 Sara Bass, 2 Xijun Zhang, 2 Laurie Burdett, 2 Belynda Hicks, 2 Sarangan Ravichandran, 3 Brian T. Luke, 3 Meredith Yeager, 2 Laura Fontaine, 4 Paula L. Hyland, 1 Alisa M. Goldstein, 1 NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, Stephen J. Chanock, 5 Neil E. Caporaso, 1 Margaret A. Tucker, 6 and Lynn R. Goldin 1 1Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 2Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 3Ad - vanced Biomedical Computing Center, Leidos Biomedical Research Inc.; Frederick National Laboratory for Cancer Research, Frederick, MD; 4Westat, Inc., Rockville MD; 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and 6Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2015.135475 Received: August 19, 2015. Accepted: January 7, 2016. Pre-published: June 13, 2016. Correspondence: [email protected] Supplemental Author Information: NCI DCEG Cancer Sequencing Working Group: Mark H. Greene, Allan Hildesheim, Nan Hu, Maria Theresa Landi, Jennifer Loud, Phuong Mai, Lisa Mirabello, Lindsay Morton, Dilys Parry, Anand Pathak, Douglas R. Stewart, Philip R. Taylor, Geoffrey S. Tobias, Xiaohong R. Yang, Guoqin Yu NCI DCEG Cancer Genomics Research Laboratory: Salma Chowdhury, Michael Cullen, Casey Dagnall, Herbert Higson, Amy A.
    [Show full text]
  • Genome‐Wide Association Study for Age at Puberty in Young Nelore Bulls
    Received: 3 May 2019 | Revised: 12 August 2019 | Accepted: 13 August 2019 DOI: 10.1111/jbg.12438 ORIGINAL ARTICLE Genome‐wide association study for age at puberty in young Nelore bulls Nedenia Bonvino Stafuzza1 | Eliane Vianna da Costa e Silva2 | Rafael Medeiros de Oliveira Silva3 | Luiz Carlos Cesar da Costa Filho2,4 | Fernanda Battistotti Barbosa2,4 | Gustavo Guerino Macedo2 | Raysildo B. Lobo5 | Fernando Baldi6 1Centro de Pesquisa em Bovinos de Corte, Instituto de Zootecnia (IZ), Abstract Sertãozinho, Brazil Selection for bulls that would reach puberty early reduces the generation interval 2Laboratório de Reprodução and increases fertility and herd productivity. Despite its economic importance, Animal, Faculdade de Medicina Veterinária there are few QTL associated with age at puberty described in the literature. In e Zootecnia (FAMEZ), Universidade Federal de Mato Grosso do Sul (UFMS), this study, a weighted single‐step genome‐wide association study was performed Campo Grande, Brazil to detect genomic regions and putative candidate genes related to age at puberty in 3 Zoetis, Edifício Morumbi Corporate ‐ young Nelore bulls. Several protein‐coding genes related to spermatogenesis func- Diamond Tower, São Paulo, Brazil tions were identified within the genomic regions that explain more than 0.5% of 4PROCRIAR Assistência Veterinária, ADAM11, Campo Grande, Brazil the additive genetic variance for age at puberty in Nelore bulls, such as 5Associação Nacional dos Criadores e BRCA1, CSNK2A, CREBBP, MEIOC, NDRG2, NECTIN3, PARP2, PARP9, PRSS21,
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7.873,482 B2 Stefanon Et Al
    US007873482B2 (12) United States Patent (10) Patent No.: US 7.873,482 B2 Stefanon et al. (45) Date of Patent: Jan. 18, 2011 (54) DIAGNOSTIC SYSTEM FOR SELECTING 6,358,546 B1 3/2002 Bebiak et al. NUTRITION AND PHARMACOLOGICAL 6,493,641 B1 12/2002 Singh et al. PRODUCTS FOR ANIMALS 6,537,213 B2 3/2003 Dodds (76) Inventors: Bruno Stefanon, via Zilli, 51/A/3, Martignacco (IT) 33035: W. Jean Dodds, 938 Stanford St., Santa Monica, (Continued) CA (US) 90403 FOREIGN PATENT DOCUMENTS (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 WO WO99-67642 A2 12/1999 U.S.C. 154(b) by 158 days. (21)21) Appl. NoNo.: 12/316,8249 (Continued) (65) Prior Publication Data Swanson, et al., “Nutritional Genomics: Implication for Companion Animals'. The American Society for Nutritional Sciences, (2003).J. US 2010/O15301.6 A1 Jun. 17, 2010 Nutr. 133:3033-3040 (18 pages). (51) Int. Cl. (Continued) G06F 9/00 (2006.01) (52) U.S. Cl. ........................................................ 702/19 Primary Examiner—Edward Raymond (58) Field of Classification Search ................... 702/19 (74) Attorney, Agent, or Firm Greenberg Traurig, LLP 702/23, 182–185 See application file for complete search history. (57) ABSTRACT (56) References Cited An analysis of the profile of a non-human animal comprises: U.S. PATENT DOCUMENTS a) providing a genotypic database to the species of the non 3,995,019 A 1 1/1976 Jerome human animal Subject or a selected group of the species; b) 5,691,157 A 1 1/1997 Gong et al.
    [Show full text]
  • Identification of Inherited Retinal Disease-Associated Genetic
    PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/183881 Please be advised that this information was generated on 2021-09-24 and may be subject to change. G C A T T A C G G C A T genes Article Identification of Inherited Retinal Disease-Associated Genetic Variants in 11 Candidate Genes Galuh D. N. Astuti 1,2, L. Ingeborgh van den Born 3, M. Imran Khan 1,4, Christian P. Hamel 5,6,7,†, Béatrice Bocquet 5,6,7, Gaël Manes 5,6, Mathieu Quinodoz 8, Manir Ali 9 ID , Carmel Toomes 9, Martin McKibbin 10 ID , Mohammed E. El-Asrag 9,11, Lonneke Haer-Wigman 1, Chris F. Inglehearn 9 ID , Graeme C. M. Black 12, Carel B. Hoyng 13, Frans P. M. Cremers 1,4 and Susanne Roosing 1,4,* ID 1 Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands; [email protected] (G.D.N.A.); [email protected] (M.I.K.); [email protected] (L.H.-W.); [email protected] (F.P.M.C.) 2 Radboud Institute for Molecular Life Sciences, Radboud University, 6525 GA Nijmegen, The Netherlands 3 The Rotterdam Eye Hospital, 3011 BH Rotterdam, The Netherlands; [email protected] 4 Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, 6525 EN Nijmegen, The Netherlands 5 Institut National de la Santé et de la Recherche Médicale, Institute for Neurosciences of Montpellier, 34080 Montpellier, France; [email protected] (B.B.); [email protected] (G.M.) 6 University of Montpellier, 34090 Montpellier, France 7 CHRU, Genetics of Sensory Diseases, 34295 Montpellier, France 8 Department of Computational Biology, Unit of Medical Genetics, University of Lausanne, 1015 Lausanne, Switzerland; [email protected] 9 Section of Ophthalmology & Neuroscience, Leeds Institute of Biomedical & Clinical Sciences, University of Leeds, St.
    [Show full text]